Unraveling Hepcidin Plasma Protein Binding: Evidence from Peritoneal Equilibration Testing
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Peptide hormone hepcidin regulates systemic iron metabolism and has been described to be partially bound to α2-macroglobulin and albumin in blood. However, the reported degree of hepcidin protein binding varies between <3% and ≈89%. Since protein-binding may influence hormone function and quantification, better insight into the degree of hepcidin protein binding is essential to fully understand the biological behavior of hepcidin and interpretation of its measurement in patients. Here, we used peritoneal dialysis to assess human hepcidin protein binding in a functional human setting for the first time. We measured freely circulating solutes in blood and peritoneal fluid of 14 patients with end-stage renal disease undergoing a peritoneal equilibration test to establish a curve describing the relation between molecular weight and peritoneal clearance. Calculated binding percentages of total cortisol and testosterone confirmed our model. The protein-bound fraction of hepcidin was calculated to be 40% (±23%). We, therefore, conclude that a substantial proportion of hepcidin is freely circulating. Although a large inter-individual variation in hepcidin clearance, besides patient-specific peritoneal transport characteristics, may have affected the accuracy of the determined binding percentage, we describe an important step towards unraveling human hepcidin plasma protein binding in vivo including the caveats that need further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Efficient filtration of hepcidin in the glomerulus is facilitated by the relatively low fraction of hepcidin that is bound by plasma protein, estimated at about 40% [28].”
From Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis (2021) · cites this paper as [28]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 1×
“Theoretically, this potential of a fast production [33,35,37] and quick turnover of hepcidin would preclude the need for protein binding [30].”
BackgroundBhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954 · cited 1×
“2 Approximately 2% of the total plasma testosterone is circulating free in both men and women [9,26]; in men 44–65% of testosterone is bound to sex hormone binding globulin and 33–54% bound to albumin; in women 66–78% of testosterone is bound to sex hormone binding globulin (MW 90 kDa), and 20–32% to albumin (MW 66,43…”
BackgroundKarl, Z. J. T., Khanna, O. N. R., Leonor, B. F. P., Ryan, P., Moore, H. L., & Nielsen, M. P. (1987) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.1177/089686088700700306 · Cited by 1,059 · cited 1×
“During a four-hour dialysis exchange, the peritoneal membrane transport function of a patient treated with PD is characterized to classify them as either a high, low, or average transporter in order to optimize the dwell time [17].”
BackgroundThe Free Hormone Hypothesis: A Physiologically Based Mathematical Model*
MENDEL, C. M. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-3-232 · Cited by 961
Immunoassay for human serum hepcidin
Ganz, T., Olbina, G., Girelli, D., Nemeth, E., & Westerman, M. (2008) · Blood · doi:10.1182/blood-2008-02-139915 · Cited by 688
Moretti, D., Goede, J. S., Zeder, C., Jiskra, M., Chatzinakou, V., Tjalsma, H., Melse-Boonstra, A., Brittenham, G., Swinkels, D. W., & Zimmermann, M. B. (2015) · Blood · doi:10.1182/blood-2015-05-642223 · Cited by 547 · cited 1×
“Theoretically, this potential of a fast production [33,35,37] and quick turnover of hepcidin would preclude the need for protein binding [30].”
BackgroundSelf-citationTime-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS
Kemna, E., Pickkers, P., Nemeth, E., van der Hoeven, H., & Swinkels, D. (2005) · Blood · doi:10.1182/blood-2005-03-1159 · Cited by 498 · cited 2×
“Moreover, circulating hepcidin concentrations can change rapidly with subsequent effects on the circulating iron levels within 1–2 h [35,36].”
BackgroundSelf-citationHepcidin in the diagnosis of iron disorders
Girelli, D., Nemeth, E., & Swinkels, D. W. (2016) · Blood · doi:10.1182/blood-2015-12-639112 · Cited by 417 · cited 4×
“Knowledge on the binding percentage of hepcidin is of great importance for correct quantification of the bioactive hormone, which in turn is key for both interpretation and standardization of hepcidin measurements in diagnostics of iron related disorders [1].”
BackgroundInfluentialSelf-citationHunter, H. N., Fulton, D. B., Ganz, T., & Vogel, H. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205305200 · Cited by 400 · cited 2×
“This might have caused nonspecific binding of hepcidin, which the molecule is prone to due to its amphipathic character [38].”
BackgroundTargeting iron metabolism in drug discovery and delivery
Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352 · cited 2×
“These therapeutics are in development for treatment of several iron metabolism disorders such as hereditary hemochromatosis or anemia of inflammation [1,14].”
Background
Cited by
Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
Nemeth, E., & Ganz, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126493 · Cited by 540
Iron and Chronic Kidney Disease: Still a Challenge
Wojtaszek, E., Głogowski, T., & Małyszko, J. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.565135 · Cited by 39
Optimizing hepcidin measurement with a proficiency test framework and standardization improvement
Aune, E. T., Diepeveen, L. E., Laarakkers, C. M., Klaver, S. M., Armitage, A. E., Bansal, S. S., Chen, M. X., Fillet, M., Han, H., Herkert, M., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0928 · Cited by 28
“A first step was made by studying the degree of hepcidin protein binding in the circulation [31], which was inconclusive.”
BackgroundSelf-citationGanz, T. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92033-2_3 · Cited by 24
Iron as Therapeutic Target in Human Diseases
Gozzelino, R., Poli, M., & Arosio, P. (2019) · Pharmaceuticals · doi:10.3390/ph12040178 · Cited by 10
“[18], who observed that this method, in the serum, might influence hormone function and quantification.”
Method
Metadata
- Authors
- Diepeveen, L. E., Laarakkers, C. M., Peters, H. P. E., van Herwaarden, A. E., Groenewoud, H., IntHout, J., Wetzels, J. F., van Swelm, R. P. L., & Swinkels, D. W.
- Affiliations
- Radboud University Medical Center (NL)
- Isala (NL)
- Department of Laboratory Medicine, Radboud University Medical Center, 6525 Nijmegen, The Netherlands
- Corresponding author
- Diepeveen, Laura E.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2019-08-23
- Volume
- 12
- Issue
- 3
- Pages
- 123
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC6789442
- OpenAlex
- W2969693410
- Cited by
- 11
- References
- 56
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 1
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- hepcidin, protein binding, plasma protein binding, peritoneal equilibration test, peritoneal dialysis, peritoneal clearance, end-stage renal disease, iron metabolism, cortisol, testosterone, interindividual variability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.